Researchers from Griffith University are seeking participants with progressive MS for STOP-MS, a trial investigating the use of antiviral drugs to reduce progression of disability in MS.
The trial will be conducted at sites across Australia.
Learn more👉 https://t.co/Cahf6WwoeL
Do you live in Ayrshire? Diagnosed with MS in the last 2 years, or waiting for answers?
Join our in-person event to pause, ask questions and connect with others who understand.
📆 Mon 1 June
🕟️ 4.30–7.30pm
➡️ https://t.co/PQFNeudpce
You don’t have to navigate MS alone 🧡
Not everyone is affected by the same #PD#symptoms, and our host Sir Nicholas Mostyn hasn't yet had to worry too much about Speech and Language #Therapy.
He tells us in the clip below his experience with his voice and advice for those keen to preserve theirs..
🔬Help shape the future of MS research in Australia
The preliminary report of @MS_Australia's Research Program review is now available on the survey page, and your feedback will help shape the next phase of MS research in Australia.
Take the survey 👉 https://t.co/FH77Q0Qx8m
https://t.co/05NYZeBG7w 📊 MS doesn’t present the same way for everyone—and understanding that matters. Catch up with the latest RealTalk MS episode exploring real stories, real research, and real progress. 🎧
#MultipleSclerosis#RealTalkMS#MSResearch
🔎 Best of #ECTRIMS2025: Pathogenesis Highlight
A study of 10M+ US military personnel led by Prof. Alberto Ascherio shows higher Vitamin D levels strongly reduce MS risk in White individuals. In Black individuals, the effect was less pronounced, pointing to further biological mechanisms.
📌 Explore the full Pathogenesis Track in the Best of ECTRIMS 2025 Slide Deck.
Download here ➡️ https://t.co/SD3oOSE78I
#ECTRIMS2025 #MSresearch #MSPathogenesis
Can you summarise your research in a 60-second ‘elevator pitch’?
We’re inviting PhD students and postdoctoral researchers to step in front of the camera for our first ever ECR video competition.
Submit your entry by 12pm on Tuesday 14 April.
Read more: https://t.co/ARzvQbofth
https://t.co/aX85uDWEni The 2026 ACTRIMS Forum reminded us that progress in MS comes from innovation and mentoring the next generation of MS researchers.
Catch up with RealTalk MS before the week starts. Listen wherever you get podcasts. 🎧
#MSResearch#RealTalkMS #MultipleSclerosis #ACTRIMS #ACTRIMSForum #ACTRIMS2026
It was great chatting to Emma Sutcliffe for an ISPEP (The International Society for Patient Engagement Professionals) PEP Talk! Available on podcast streaming channels and via the ISPEP hub.
https://t.co/DDs2hI57HV
It’s important not to be hard on yourself if it’s hard to stick to goals.
Especially because living with MS can be unpredictable.
Meet Amy 👋 She tells us how the spoon theory has helped her be kind to herself 🥄 And to be flexible.
Read Amy’s story: https://t.co/rs9RrA6INy
Government has extended the UK Rare Disease Framework. But with people with rare neurological conditions continuing to face delays to diagnosis, insufficient care coordination and poor access to treatment, this extension must be used widely
More at https://t.co/Qe5HozRNbo
https://t.co/IXy3fLs1Md Progression without relapses? PIRA can feel confusing—especially with a relapsing-remitting MS diagnosis. Dr. Stephen Krieger helps make sense of it on RealTalk MS. 🎧 #MultipleSclerosis#RealTalkMS@SKriegerMD
At #PxP25, we hosted three unique sessions that weren’t recorded for our YouTube channel to create a safe space for open dialogue. Check out the anonymized illustrations from these sessions here, along with other artwork from this year’s conference:
https://t.co/HXtNIOHQR5
The recording for the Asian MS webinar "Exploring healthcare experiences of Black and South Asian people affected by MS" is now available to watch on YouTube! https://t.co/W2SJbPBS1r
I just signed @PCR_News' petition calling for the Government to commit to a national prostate cancer screening programme for all high-risk men. Screening will save lives. Join me and add your name! #prostatecancer https://t.co/gakI190xYf
The McDonald Diagnostic Criteria for MS have now been published, offering clinicians tools to support earlier diagnosis & improve health outcomes.
Adoption into clinical practice is expected to follow as awareness & access to diagnostic tools grow.
https://t.co/q9zp8DD16g